Clinical Trials on Advanced/Metastatic Solid Malignancies in Netherlands
Total 150 results
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesNetherlands
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid Tumor | Metastatic Solid TumorNetherlands
-
University Medical Center GroningenActive, not recruiting
-
Amsterdam UMC, location VUmcTerminatedAdvanced or Metastatic Solid MalignancyNetherlands
-
Amsterdam UMC, location VUmcCompletedColorectum Advanced Malignancies | Breast Advanced Malignancies | Prostate Advanced MalignanciesNetherlands
-
Merck Sharp & Dohme LLCRecruitingNeoplasms | Advanced/Metastatic Solid TumorsCanada, Israel, United States, Netherlands
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
AstraZenecaTerminatedCancer | Advanced Solid MalignanciesUnited States, Italy, United Kingdom, France, Germany, Spain, Netherlands
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownAdvanced MalignanciesNetherlands
-
Hoffmann-La RocheCompletedAdvanced/Metastatic Solid TumorsUnited States, Belgium, Denmark, Spain, Netherlands, Canada, Italy
-
Crescendo Biologics Ltd.University Medical Center GroningenActive, not recruitingAdvanced and/or Metastatic Solid TumoursNetherlands
-
University Medical Center GroningenTerminatedMetastatic MalignanciesNetherlands
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Amsterdam UMC, location VUmcVitrOmics BVTerminatedAdvanced Solid Tumors | Metastasis | InoperableNetherlands
-
Merck Sharp & Dohme LLCRecruitingAdvanced or Metastatic Solid TumorsUnited States, Canada, Israel, Netherlands
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
Foundation CPCTHartwig Medical FoundationActive, not recruiting
-
P.O. WitteveenErasmus Medical Center; The Netherlands Cancer InstituteTerminated
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
Radboud University Medical CenterCATO-SMSRecruitingAdvanced Solid TumorNetherlands
-
University Medical Center GroningenRecruiting
-
University Medical Center GroningenRegeneron PharmaceuticalsActive, not recruiting
-
Eisai Inc.Completed
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyRecruitingAdvanced Solid TumorNetherlands
-
Amsterdam UMC, location VUmcCompletedCancer | Advanced Solid TumorsNetherlands
-
Crescendo Biologics Ltd.RecruitingAdvanced and/or Metastatic Solid TumoursSpain, United Kingdom, Netherlands, United States
-
Clovis Oncology, Inc.CompletedAdvanced Solid TumorNetherlands
-
Cristal TherapeuticsCompletedCancer | Metastatic Cancer | Solid TumorsNetherlands, Belgium
-
Debiopharm International SARecruitingAdvanced Solid TumorsNetherlands, Spain
-
Radboud University Medical CenterBayerCompletedAdvanced Solid Tumor | Refractory to Standard TherapiesNetherlands
-
Millennium Pharmaceuticals, Inc.Completed
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
Eisai Inc.Completed
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, Netherlands
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedSolid Tumors | Hematologic MalignanciesNetherlands
-
AbbVieCompletedCancer | Advanced Solid Tumors | Hematologic MalignanciesUnited States, Japan, Netherlands, Spain
-
Kling Biotherapeutics B.V.RecruitingAdvanced Solid Tumor MalignancyBelgium, Netherlands
-
Taiho Oncology, Inc.TerminatedAdvanced Solid TumorsItaly, Spain, United States, Netherlands, United Kingdom
-
Cytovation ASMerck Sharp & Dohme LLCActive, not recruitingAdvanced Solid Tumor MalignancyNetherlands, France, Spain
-
Vall d'Hebron Institute of OncologyTaisho Pharmaceutical Co., Ltd.; Roche Pharma AG; Iqvia Pty Ltd; Janssen, LPRecruitingAdvanced Solid TumorSpain, France, Germany, Netherlands, Sweden, United Kingdom, Italy
-
Molecular Partners AGTerminatedAdvanced Malignant Solid TumorNetherlands, France
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
AstraZenecaCompletedSafety and Tolerability, | Advanced Solid Malignancy, | Pharmacokinetics, Pharmacodynamics, | Tumour Response,United Kingdom, Netherlands
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Advanced Solid TumorSpain, United States, Netherlands, United Kingdom
-
T-knife GmbHTerminatedAdvanced Solid TumorsGermany, Belgium, Spain, Netherlands, United Kingdom